Evidence map›Paper›PMID 38040775›Full record

ArticleScientific reports2023

Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.

Matthieu Béreau, Anna Castrioto, Mathieu Servant, Eugénie Lhommée, Maxime Desmarets, Amélie Bichon, Pierre Pélissier, Emmanuelle Schmitt, Hélène Klinger, Nadine Longato and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Is motor asymmetry a predictor of non-motor outcomes in Parkinson's disease?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 2 countries.

Matthieu BéreauNeurology Department, University Hospital of Besançon, CHRU de Besançon, 3 Bd Alexandre Fleming, 25030, Besançon Cedex, France. mbereau@chu-besancon.fr.
Anna CastriotoInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Mathieu ServantLaboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR LINC, Université Bourgogne Franche-Comté, Besançon, France.
Eugénie LhomméeInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Maxime DesmaretsUnité de Méthodologie, CIC INSERM 1431, CHU de Besançon, Besançon, France.
Amélie BichonInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Pierre PélissierInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Emmanuelle SchmittInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Hélène KlingerMovement Disorders Unit, Neurology Department, Hospices Civils de Lyon, Lyon, France.
Nadine LongatoService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Clélie PhillippsService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Thomas WirthService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Valérie FraixInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Isabelle BenatruNeurology Department, University Hospital of Poitiers, Poitiers, France.
Franck DurifEA7280 NPsy-Sydo, Université Clermont Auvergne, Clermont-Ferrand, France.
Jean-Philippe AzulayMovement Disorders Unit, Neurology Department, University Hospital of Marseille, Marseille, France.
Elena MoroInserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
Emmanuel BroussolleMovement Disorders Unit, Neurology Department, Hospices Civils de Lyon, Lyon, France.
Stéphane ThoboisMovement Disorders Unit, Neurology Department, Hospices Civils de Lyon, Lyon, France.
Christine TranchantService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Paul KrackDepartment of Neurology, Movement Disorders Center, University Hospital of Bern, Bern, Switzerland.
Mathieu AnheimService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Inserm · FRHôpitaux Universitaires de Strasbourg · FRUniversité Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRAssistance Publique Hôpitaux de Marseille · FRCentre Hospitalier Universitaire de Besançon · FRUniversité Bourgogne Franche-Comté · FRUniversité Clermont Auvergne · FRUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few studies have considered the influence of motor sign asymmetry on motivated behaviors in de novo drug-naïve Parkinson's disease (PD). We tested whether motor sign asymmetry could be associated with different motivated behavior patterns in de novo drug-naïve PD. We performed a cross-sectional study in 128 de novo drug-naïve PD patients and used the Ardouin Scale of Behavior in Parkinson's disease (ASBPD) to assess a set of motivated behaviors. We assessed motor asymmetry based on (i) side of motor onset and (ii) MDS-UPDRS motor score, then we compared right hemibody Parkinson's disease to left hemibody Parkinson's disease. According to the MDS-UPDRS motor score, patients with de novo right hemibody PD had significantly lower frequency of approach behaviors (p = 0.031), including nocturnal hyperactivity (p = 0.040), eating behavior (p = 0.040), creativity (p = 0.040), and excess of motivation (p = 0.017) than patients with de novo left hemibody PD. Patients with de novo left hemibody PD did not significantly differ from those with de novo right hemibody PD regarding avoidance behaviors including apathy, anxiety and depression. Our findings suggest that motor sign asymmetry may be associated with an imbalance between motivated behaviors in de novo drug-naïve Parkinson's disease.

Indexed as

ApathyParkinson DiseaseAnxietyAnxiety DisordersCross-Sectional StudiesHumans

Identifiers

PMID38040775
PMCPMC10692157
OpenAlexW4389220581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.